BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference

46 th Annual TD Cowen Healthcare Conference: Interested parties may access live and archived webcasts of the presentations on the “investors” section of the Company’s website at: ...
MarketWatch

BioStem Technologies Expands Product Access in Medicaid

The MarketWatch News Department was not involved in the creation of this content. POMPANO BEACH, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech ...
Yahoo Finance

BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results

BioStem’s financial results for the second quarter 2024 and 2025 included in this press release are preliminary, unaudited and subject to finalization of BioStem’s audited financial statements for the ...
Business Insider

BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

Decision ensures continued patient access to VENDAJE ® and VENDAJE AC ® POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused ...

BioStem Technologies Inc.

BioStem Technologies Inc. company and executive profile by Barron's. View the latest BSEM company infomation and executive ...
Yahoo Finance

BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business

POMPANO BEACH, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of ...
Seeking Alpha

BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

POMPANO BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem”, “we”, “us”, or “our”), a leading MedTech ...
Morningstar

BioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025

POMPANO BEACH, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of ...
Nasdaq

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

Conference call and webcast to be held at 4:30 PM ET Forward-Looking Statements: Except for statements of historical fact, this release also contains forward-looking statements within the meaning of ...
manilatimes

BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research

POMPANO BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal ...
Seeking Alpha

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or ...
manilatimes

BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of ...